Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

2018 hot consumer trends: technology turns human

· Consumers expect technology interactions to be controlled by intonation, facial expression and body language · Earphones will become a 24/7 accessory, even when sleeping · 51 percent of Augmented Reality/Virtual Reality users believe artificial intelligence (AI) will render ads indistinguishable from the actual productsExploring the future from an early adopter user perspective, Ericsson (NASDAQ: ERIC) ConsumerLab presents the seventh edition of its annual trend report, The 10 Hot Consumer Trends for 2018 and beyond 

Panion’s epilepsy product classified as MUMS in EU for dogs and cats

Panion Animal Health AB has received the European Medicines Agency’s acceptance of the classification as MUMS (Minor Use Minor Species) for our epilepsy product for both dogs and cats. The request for classification was submitted to the Committee for Medicinal Products for Veterinary Use (CVMP) in the European Medicines Agency (EMA) earlier in 2017 and has now been successfully evaluated.The MUMS status is granted to assist applicants that intends to develop and submit applications for products for limited markets in order to stimulate development of new medicines. The measures made

Pihlajalinna appoints new CEO

Pihlajalinna Plc     Stock Exchange Release    11 December 2017 at 9:55 Pihlajalinna appoints new CEO The Board of Directors of Pihlajalinna and CEO Aarne Aktan have agreed that Aktan will leave his position as the CEO. “We thank Aarne Aktan for his work for Pihlajalinna as board member and CEO during more than three years”, says Mikko Wirén, the Chairman of Pihlajalinna's Board of Directors. The Board of Directors of Pihlajalinna Plc has appointed Joni Aaltonen, currently SVP, P&S segment and Head of Corporate Planning of Pihlajalinna group, as new CEO of Pihlajalinna Plc. The

Staffan Persson declines re-election in Cinnober

Cinnober's board member Staffan Persson has announced to the company that he declines re-election before the 2018 AGM. Staffan Persson currently holds a shareholding in Cinnober corresponding to 2.9 % and has been a member of the board since 2011. For further information or discussion, please contact:Fredrik Backlund                                    Head of Corporate Communications                                                          Cinnober                                              +46 73 403 12 39                                               fredrik.backlund@

New Chief Financial Officer at Swedish Match

Swedish Match today announced that Marlene Forsell has decided to resign as Chief Financial Officer for family reasons and that she will leave her position on March 9, 2018. She will be replaced by Tom Hayes who is currently Vice President Business Control and CFO in Swedish Match’s US Division.CEO Lars Dahlgren’s comment: Marlene joined our company in 2004 and became CFO in 2013. Throughout her successful career at Swedish Match she has made many important contributions to our Company. We are very sorry that Marlene has decided to resign. We are fortunate to have a strong replacement

Climeon steps up - first volume order approved for delivery

Climeon achieved a key milstone when successfully passing the Factory Acceptance Test of the first volume order. The first six Climeon Heat Power units, out of totally 18, are being prepared for delivery to Fincantieris shipyard i Romania.Representatives from Fincantieri, Lloyd’s Register and the ship owner attended the Factory Acceptance Test to verify performance, safety and quality of the products before shipment to Fincantieris shipyard in Romania. Thomas Öström, CEO at Climeon, comments: “This is a key milestone for us that makes 2017 the year we went from single module production

Change in number of shares in BrainCool AB (publ)

Conversion of convertible notes into shares, as part of the financing agreement announced 23 November 2017The number of convertible notes converted on December 11, 2017, was 30. The number of convertible notes remaining under the first Tranche for future conversion is 170. The number shares and the number of votes before the conversion was 33 884 292. Through this conversion, and once the shares from the conversion will be registered at Bolagsverket, the number of shares and the number of votes shall have increased by 385 109. The total number of shares and total number of votes after this

The diabetes vaccine Diamyd® shows positive results

Diamyd Medical today announced results from DIAGNODE-1, when all patients have been followed for 6 months. A clinically relevant and positive progression can be demonstrated in terms of the body’s own capacity to produce insulin, as well as long-term blood sugar and insulin dose. No serious adverse events have been reported."The results seen in DIAGNODE-1 are gratifying, now that all twelve patients have been followed for 6 months," says Johnny Ludvigsson, Professor at Linköping University and Sponsor of the trial. “It is therefore with enthusiasm that we start DIAGNODE-2, where we have now

NetEnt signs distribution agreement with IGT for Norsk Tipping

NetEnt, a leading provider of digital casino content solutions, has signed an agreement with IGT to supply online casino games to Norsk Tipping, the state lottery in Norway.Earlier this year, NetEnt participated as a supplier to IGT in the competitive procurement process of Norsk Tipping for the delivery of online casino content. Norsk Tipping is Norway's state lottery operator and a World Lottery Association (WLA) member. Following a successful tender process, IGT announced in February of this year that it had won a contract with Norsk Tipping to provide online casino games. For more

Catella Wohnen Europa investment fund acquires 215 residential units in Germany and Netherlands

Berlin-based investment manager Catella Residential Investment Management GmbH, a subsidiary of the Swedish Catella Group focused exclusively on the residential asset class, has, on behalf of Catella Wohnen Europa investment fund, acquired a total of 215 residential units in Lübeck, Germany, and Den Bosch, the Netherlands, for EUR 27.2 million.“While the structure of each of the properties has evolved over time, the buildings have been brought up to modern standards. This makes them a perfect fit for the long-term focus of our portfolio. In addition, we had already acquired a residential

Passenger increase at Swedavia’s airports in November

In November, 3,300,000 passengers flew to or from one of Swedavia’s ten airports in Sweden – a three per cent increase compared to November 2016. International traffic was up four per cent to 2,000,000 passengers. Domestic traffic was up one per cent compared to the same period last year to 1,260,000 passengers. Some 2,000,000 passengers flew to or from Stockholm Arlanda Airport in November, a four per cent increase compared to the same period last year. Of these, 1,560,000 were international passengers, a four per cent increase. Domestic traffic increased two per cent to 495,000

Update on Tawke PSC

11 December 2017 Genel Energy plc Update on Tawke PSC Genel Energy plc ('Genel') notes that DNO ASA, as operator of the Tawke PSC, has today issued an update on licence activity: Production from the Peshkabir field in the Tawke licence in the Kurdistan Region of Iraq has tripled to 15,000 bopd following completion of the Peshkabir-3 well testing, stimulation and clean-up program. A total of 11 zones in a 1.2 kilometre horizontal section of Cretaceous and Jurassic reservoir in the Peshkabir-3 well were individually tested and flowed successfully, of which ten were oil zones

Avanza has Sweden’s most satisfied savers

For the eighth consecutive year, Avanza has won the award for Sweden’s most satisfied customers in the savings category, based on an annual survey conducted by the Swedish Quality Index (SQI).“Satisfied customers are our most important target and the very foundation of our business model. We are extremely proud to have again lived up to our customers’ high expectations. This year we have passed 700,000 customers and therefore also see this award as proof that we have successfully managed the record-high-growth without sacrificing the customer experience,” says Rikard Josefson, CEO of Avanza.

Bonava to donate a quarter million SEK to SOS Children's Villages

Bonava’s 1,600 employees have chosen to donate this year’s Christmas gift of a quarter million Swedish krona to SOS Children's Villages . Instead of giving out Christmas gifts to employees, Bonava has prioritised a donation to an organisation that helps people in need.- Last year, we began a new tradition at Bonava. Instead of Christmas gifts to all our employees, we donated the money to people in need, around the world. SOS Children's Villages 

Directorate Change

ENQUEST PLC, 11 December 2017. Directorate change EnQuest PLC ('EnQuest') announces that Neil McCulloch is stepping down today as Chief Operating Officer and Executive Director of EnQuest PLC by mutual agreement. EnQuest has appointed Faysal Hamza as Interim Head of North Sea and Bob Davenport as Managing Director, North Sea, reporting to Faysal. Prior to joining EnQuest, Bob successfully led Apache's North Sea operations. Faysal and Bob previously worked together to build EnQuest's successful business in Malaysia. John Penrose will replace Bob as Managing Director, Malaysia.

KONE acquires Hong Kong based Shan On Engineering Company Limited

KONE Corporation, press release, December 11, 2017 KONE Corporation, a global leader in the elevator and escalator industry, has acquired Shan On Engineering Company Limited in Hong Kong. Founded in 1973, Shan On is specialized in elevator maintenance, modernization and installation services and today has approximately 1,000 elevators in its maintenance base. Previously, KONE owned 35.3% of the company and has now bought the remaining 64.7% shareholding. With this acquisition, KONE will strengthen its market position in the region. "We warmly welcome Shan On and its skilled

Sweco expands in Belgium

Sweco is acquiring the operations of HaskoningDHV Belgium after concluding an asset purchase agreement with Royal HaskoningDHV. HaskoningDHV Belgium is specialised in soil investigations and decontamination, environmental impact assessments and integrated area development. This acquisition will further strengthen Sweco’s position on the Belgian market."I am pleased to welcome HaskoningDHV Belgium to Sweco. Sweco has a very solid base in Belgium. We have an efficient organisation and are continuously growing. The experts from HaskoningDHV Belgium are a perfect match for our multidisciplinary

Read original

Capio continues to invest in digital healthcare

Capio is strengthening its involvement in the development of digital healthcare solutions by investing MSEK 49 in the new share issue of MSEK 100 that was announced by the e-health provider Doctrin today. By investing, Capio is participating in the development of new digital applications based on artificial intelligence, increasing efficiency in healthcare provision and improving patient experience.Capio and Doctrin are collaborating since late 2016. During fall this year, implementation of the new digital tools “Better Visits” and “Online Consultations” (Läkarbesök Online) started in Capio’

Yeast can be engineered to create protein pharmaceuticals

It took several years, but a research team headed by Professor Jens Nielsen at Chalmers University of Technology has finally succeeded in mapping out the complex metabolism of yeast cells. The breakthrough, recently published in an article in Nature Communications, means a huge step forward in the potential to more efficiently produce protein therapies for diseases such as cancer. The market for pharmaceuticals that mimic the body’s own proteins – protein-based therapeutics – is exploding. Some of them are relatively simple to manufacture in yeast-based cell factories. Insulin and HPV

Targovax announces that first combination trials with ONCOS-102 have passed their initial, planned, independent safety reviews

Oslo, Norway, 11 December 2017 - Targovax ASA (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, announces that clinical trials investigating ONCOS-102 in the treatment of melanoma and mesothelioma have successfully passed their respective first, planned, independent safety reviews. These are the first studies to investigate ONCOS-102 in combination with other drugs. The safety reviews of ONCOS-102 in the first four patients in the melanoma trial and first three patients in the mesothelioma trial have been completed without any

Betalutin® shows strong clinical profile in relapsed/refractory indolent NHL and follicular lymphoma

Updated data reported at the 59th Annual American Society of Hematology (ASH) meetingOslo, Norway, 11 December 2017 Nordic Nanovector ASA (OSE: NANO) has presented updated results from its LYMRIT 37-01 Phase 1/2 clinical study of Betalutin® (177Lu-satetraxetan-lilotomab) in patients with relapsed/refractory (R/R) indolent NHL (iNHL) at the 59th Annual ASH meeting (9-12 December 2017 in Atlanta, GA, USA). A conference call and audio cast to present the results will take place today at 08:00 CET – details below. The updated data continue to highlight Betalutin®’s strong clinical profile

BerGenBio Presents Update on Ph II Clinical Trial with Selective AXL Inhibitor BGB324 in Relapsed/Refractory AML Patients at 59th ASH Annual Meeting

35 relapsed/refractory AML and MDS patients received BGB324 as monotherapy; two CRi and five PR were observed, and seven patients stayed on treatment for more than four months. Three novel and proprietary predictive biomarker candidates were identified.Bergen, Norway, 11 Dec 2017 – BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company focused on developing a pipeline of first-in-class AXL kinase inhibitors to treat multiple cancer indications, today announced that it presented an update on the BGBC003 clinical trial (NCT02488408) with selective AXL inhibitor BGB324 in

SEK 4 billion into investment funds in November

In November, investment funds recorded a total net inflow of SEK 4.2 billion. Net deposits were primarily made in bond funds and balanced funds, whereas money market funds and equity funds recorded net withdrawals. The total fund assets in Sweden decreased during the month with SEK 3 billion and amounted at the end of November to SEK 3 993 billion.Investment funds recorded a total net inflow of SEK 4.2 billion in November. Bond funds had net deposits of SEK 3.5 billion and balanced funds had net deposits of SEK 2.9 billion. Money market funds and equity funds, on the other hand, recorded

Starbreeze releases new cinematic trailer for OVERKILL’s the Walking Dead revealing the co-op action shooter’s first character, Aidan

A new cinematic trailer was released today for OVERKILL’s The Walking Dead, the upcoming cooperative first-person shooter in development by OVERKILL – A Starbreeze Studio, together with its partners Skybound Entertainment and 505 Games. This video features Aidan, the first of the game’s four unique playable characters fighting to stay alive in a post-apocalyptic world. Watch the trailer here: https://youtu.be/non_0jlOXew Inspired by the rich story universe of Robert Kirkman’s original graphic novels, OVERKILL’s The Walking Dead is a four-player co-op multiplayer FPS action game set in

There are no items matching the current filter
There are no more items matching the current filter
Back to top